UGT1A13P

Across TCGA pan-cancer cohorts, UGT1A13P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of UGT1A13P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where UGT1A13P RNA is repressed in tumor relative to normal tissue. In most cancer types UGT1A13P is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

COAD, KIRC, and PAAD are the cancer types where UGT1A13P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UGT1A13P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	−0.133	<.001	7	view →
KIRC	All	All	+0.035	<.001	7	view →
PAAD	All	All	+0.310	.040	2	view →
LUSC	All	All	+0.032	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

UGT1A13P–COAD

Open the COAD breakdown →